Related Experiment Videos
[Abnormal function of lipoprotein receptors in the monocytes of hypercholesteremic patients]
G Paragh1, Z Varga, M Szabolcs
1Debreceni Orvostudományi Egyetem, I. Belgyógyászati Klinika.
Insights
Familial hypercholesterolemia (HCh) involves genetic defects in LDL receptors. This study found impaired LDL degradation, not just binding, is a key factor in cholesterol abnormalities in HCh patients.
Area of Science:
- Biochemistry
- Genetics
- Metabolic Disorders
Context:
- Familial hypercholesterolemia (HCh) is a genetic disorder characterized by high LDL cholesterol levels.
- Low-density lipoprotein (LDL) receptors are crucial for cholesterol metabolism, regulating intracellular cholesterol synthesis and preventing cellular accumulation.
- Defects in LDL receptors lead to HCh, impacting cholesterol homeostasis.
Purpose:
- To investigate LDL receptor activity, number, binding, and degradation in patients with familial hypercholesterolemia.
- To evaluate how intracellular cholesterol regulates synthesis in HCh patients.
- To compare monocyte-derived macrophages from HCh patients and healthy controls.
Summary:
- This study examined 58 HCh patients and healthy controls, focusing on monocyte-derived macrophages which possess both specific and scavenger receptors.
- Results indicated that decreased binding to LDL receptors was observed in only 6 patients, with elevated cholesterol synthesis.
- Impaired LDL degradation, rather than solely reduced binding, appears to be a more common cause of cholesterol abnormalities in HCh.
Impact:
- Highlights that impaired LDL degradation is a significant factor in familial hypercholesterolemia pathophysiology.
- Suggests multiple metabolic steps within the intracellular degradation process can be compromised in HCh patients.
- Provides insights into the complex mechanisms underlying cholesterol metabolism defects in genetic hypercholesterolemia.
Abstract:
The familial hypercholesterinemia (HCh) is as a genetically determined disorder. The genetical damage and functional abnormalities of the LDL receptors lead to familial Hch. The LDL plays an important role in cholesterol metabolism. They carry cholesterol which metabolizes through specific and scavenger LDL receptors. The ApoB100 particle of LDL binds to the receptors, internalizated, and digested, and the remaining free cholesterol regulates the intracellular cholesterol synthesis. It inhibits the key enzyme, HMG-CoA reductase and decreases the LDL receptor synthesis and increases cholesterol esterification. These mechanism can prevent the cholesterol accumulation of the cells. The aim of the present study was to clarify the activity and number of the LDL receptor, to study the LDL binding and degradation and to evaluate how the intracellular cholesterol can regulate the synthesis in patients with HCh. 58 pts with HCh and their monocytes were investigated, because the monocyte derived macrophages contained both specific and scavenger receptors. Monocytes of the pts were compared to the healthy individual controls. From the results it could be recognized--that the decreased binding to the specific LDL receptors only at 6 pts cholesterol synthesis was elevated in HCh pts group, while the synthesis inhibition induced by 50 micrograms LDL was decreased. The presented experimental results suggested that the decreased binding ability to LDL receptors is a rare cause of cholesterol abnormalities, while during the intracellular degradation process more metabolic steps can be damaged in patients with HCh.